Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 251-275 of 2,022
Not Yet RecruitingNCT07369401

Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory Schizophrenia

This study is looking at whether a digital support tool can help people with Refractory Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Global
Sponsor
First Affiliated Hospital of Fujian Medical University
Condition
Schizophrenia
Not Yet RecruitingNCT07342465

Gamma Light and Sound Stimulation in Schizophrenia

This study is comparing GENUS with Sham Stimulation for people with Schizophrenia Spectrum Disorders. Participants receive GENUS or Sham Stimulation and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts Institute of Technology
Condition
Schizophrenia
Active Not RecruitingNCT04338152

Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial

This study is looking at whether problem-solving support can help people with psychosis, Prodromal Symptoms, Prodromal Schizophrenia, or Family. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 13 Years to 25 Years
Countries
Canada, United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
RecruitingNCT06568081

SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

This observational study is looking at how a digital support tool works for people with Schizophrenia Spectrum and Other psychosis or Affective Psychoses in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
RecruitingNCT05208190

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

This observational study is following people with Schizophrenia or schizoaffective disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
RecruitingNCT04370730

Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 7 Years to 20 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
Enrolling By InvitationNCT05165316

European Long-acting Antipsychotics in Schizophrenia Trial-II

This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherOver 18 Years
Countries
Israel
Sponsor
Rene Kahn
Condition
Schizophrenia
Active Not RecruitingNCT07351240

The Acupuncture Treatment Effect in Patients With Schizophrenia

This study is looking at whether a digital support tool can help people with Mental Health. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
Calo Psychiatric Center
Condition
Schizophrenia
Enrolling By InvitationNCT07359209

Berberine Improving Cognitive Impairments in Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia Therapeutics. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Tianjin Anding Hospital
Condition
Schizophrenia
RecruitingNCT05316883

Biomarkers in Clozapine-responding Schizophrenia

This observational study is following people with Schizophrenia or Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
Denmark
Sponsor
Jimmi Nielsen
Condition
Schizophrenia
RecruitingNCT07343193

Deprescribing Antipsychotics: a Multiple Case Study

This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Not Yet RecruitingNCT07342764

Comparative Effectiveness of Dapagliflozin, Metformin, and Lifestyle Modification for Antipsychotic-Induced Weight Gain: An Open-Label Pragmatic Trial

This study is looking at whether a digital support tool can help people with Antipsychotic-induced Weight Gain or Schizophrenia Spectrum and Other psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 16 Years to 60 Years
Countries
Oman
Sponsor
Sultan Qaboos University
Condition
Schizophrenia
WithdrawnNCT06142422

Intermittent Theta Burst Stimulation of the Precuneus

This study is looking at whether stimulation device can help people with Schizophrenia. Participants take part in stimulation device and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Global
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition
Schizophrenia